scispace - formally typeset
L

Li Deng

Researcher at University of Texas Southwestern Medical Center

Publications -  8
Citations -  6750

Li Deng is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Ubiquitin ligase & CHUK. The author has an hindex of 8, co-authored 8 publications receiving 6341 citations. Previous affiliations of Li Deng include University of Texas at Dallas & Cleveland Clinic.

Papers
More filters
Journal ArticleDOI

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

TL;DR: The purification and identification of TRIKA2, which is composed of TAK1, TAB1 and TAB2, a protein kinase complex previously implicated in IKK activation through an unknown mechanism, indicate that ubiquitination has an important regulatory role in stress response pathways, including those of IKK and JNK.
Journal ArticleDOI

Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain

TL;DR: It is found that TRAF6, a RING domain protein, functions together with Ubc13/Uev1A to catalyze the synthesis of unique polyubiquitin chains linked through lysine-63 (K63) of ubiquitin.
Journal ArticleDOI

Activation of IKK by TNFα Requires Site-Specific Ubiquitination of RIP1 and Polyubiquitin Binding by NEMO

TL;DR: The results reveal the biochemical mechanism underlying the essential signaling function of NEMO and provide direct evidence that signal-induced site-specific ubiquitination of RIP1 is required for IKK activation.
Journal ArticleDOI

TAB2 and TAB3 Activate the NF-κB Pathway through Binding to Polyubiquitin Chains

TL;DR: Evidence is presented that TAB2 and TAB3 are receptors that bind preferentially to lysine 63-linked polyubiquitin chains through a highly conserved zinc finger (ZnF) domain, which indicates that polyubanquitin binding domains represent a new class of signaling domains that regulate protein kinase activity through a nonproteolytic mechanism.
Journal ArticleDOI

The TRAF6 Ubiquitin Ligase and TAK1 Kinase Mediate IKK Activation by BCL10 and MALT1 in T Lymphocytes

TL;DR: Evidence is presented that TRAF6 ubiquitin ligase and TAK1 protein kinase mediate IKK activation by BCL10 and MALT1, and a small fraction of these proteins form high molecular weight oligomers, which culminates in NF-kappaB activation in T lymphocytes.